MRNA COVID-19 Vaccine and Hope to Cure Cancer

Authors

  • Ajay Kumar Yadav Department of Radio-diagnosis, Imaging and Nuclear Medicine, BP Koirala Memorial Cancer Hospital, Bharatpur, Nepal
  • Suman Gnawali Department of Radio-diagnosis, Imaging and Nuclear Medicine, BP Koirala Memorial Cancer Hospital, Bharatpur, Nepal
  • Gangbiao Yuan Department of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, PR China

DOI:

https://doi.org/10.3126/njc.v5i1.41363

Keywords:

MRNA, COVID, Cancer Vaccine

Abstract

There is hope that cancer patient should benefit from mRNA COVID-19 vaccination. Some of the most advanced candidate vaccines are encapsulated in carriers of lipids, and small liposomes are expected to accumulate in tumor tissue through the enhanced effect of permeation and retention. However, the extent to which solid tumors might take a significant part of the vaccine dose, so it is still unknown. This requires a careful evaluation of these promising vaccines of mRNA COVID-19 managed as carriers of lipids for patients with solid tumors, including a possible revaluation of the assay for optimal protection of this specification and the fragile population. 

Downloads

Download data is not yet available.
Abstract
74
PDF
72

Downloads

Published

2021-09-26

How to Cite

Yadav, A. K., Gnawali, S., & Yuan, G. (2021). MRNA COVID-19 Vaccine and Hope to Cure Cancer. Nepalese Journal of Cancer, 5(1), 83–85. https://doi.org/10.3126/njc.v5i1.41363

Issue

Section

Short Communications